|
[1]
|
Tapioca Resistant Maltodextrin as a Carbohydrate Source of Oral Nutrition Supplement (ONS) on Metabolic Indicators: A Clinical Trial
Nutrients,
2022
DOI:10.3390/nu14050916
|
|
|
|
|
[2]
|
Blood Glucose Response of a Low-Carbohydrate Oral Nutritional Supplement with Isomaltulose and Soluble Dietary Fiber in Individuals with Prediabetes: A Randomized, Single-Blind Crossover Trial
Nutrients,
2022
DOI:10.3390/nu14122386
|
|
|
|
|
[3]
|
Functional Cereals and Cereal Foods
2022
DOI:10.1007/978-3-031-05611-6_5
|
|
|
|
|
[4]
|
Effects of consumption of a low glycaemic index formula on glycaemic control in patients with type 2 diabetes managed by medical nutrition therapy
Food Science and Technology,
2021
DOI:10.1590/fst.51320
|
|
|
|
|
[5]
|
Attenuation of glycaemic and insulin responses following tapioca resistant maltodextrin consumption in healthy subjects: a randomised cross-over controlled trial
Journal of Nutritional Science,
2020
DOI:10.1017/jns.2020.22
|
|
|
|
|
[6]
|
Effect of Oral Nutritional Supplements with Sucromalt and Isomaltulose versus Standard Formula on Glycaemic Index, Entero-Insular Axis Peptides and Subjective Appetite in Patients with Type 2 Diabetes: A Randomised Cross-Over Study
Nutrients,
2019
DOI:10.3390/nu11071477
|
|
|
|
|
[7]
|
D-Tagatose Is a Promising Sweetener to Control Glycaemia: A New Functional Food
BioMed Research International,
2018
DOI:10.1155/2018/8718053
|
|
|
|
|
[8]
|
Use of Oral Nutritional Supplements for Patients with Diabetes
The Journal of Korean Diabetes,
2017
DOI:10.4093/jkd.2017.18.3.181
|
|
|
|
|
[9]
|
Glycaemic response after intake of a high energy, high protein, diabetes-specific formula in older malnourished or at risk of malnutrition type 2 diabetes patients
Clinical Nutrition,
2017
DOI:10.1016/j.clnu.2017.09.027
|
|
|
|
|
[10]
|
Impact of Diabetes-Specific Nutritional Formulas versus Oatmeal on Postprandial Glucose, Insulin, GLP-1 and Postprandial Lipidemia
Nutrients,
2016
DOI:10.3390/nu8070443
|
|
|
|
|
[11]
|
Effect of Carbohydrate Restriction in Patients with Hyperinsulinemic Hypoglycemia after Roux-en-Y Gastric Bypass
Obesity Surgery,
2014
DOI:10.1007/s11695-014-1319-6
|
|
|
|